Virtu Financial’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-10,138
Closed -$189K 2095
2025
Q2
$189K Buy
+10,138
New +$201K 0.01% 935
2022
Q1
Sell
-6,877
Closed -$1.03M 2034
2021
Q4
$1.03M Buy
+6,877
New +$928K 0.11% 186
2020
Q4
Sell
-8,622
Closed -$979K 1797
2020
Q3
$979K Buy
+8,622
New +$906K 0.17% 126
2019
Q4
Sell
-5,095
Closed -$301K 1850
2019
Q3
$301K Buy
5,095
+162
+3% +$10.3K 0.02% 756
2019
Q2
$318K Sell
4,933
-2,867
-37% -$185K 0.02% 760
2019
Q1
$495K Buy
+7,800
New +$410K 0.03% 567
2018
Q1
Sell
-27,308
Closed -$64K 2601
2017
Q4
$64K Buy
27,308
+17,351
+174% +$54.5K ﹤0.01% 2029
2017
Q3
$73K Buy
+9,957
New +$63K ﹤0.01% 2152

Other funds holding TNDM

Virtu Financial's TNDM Position: Q3 2025 in Review

Virtu Financial sold out of Tandem Diabetes Care (TNDM) in Q3 2025, closing a stake of 10,138 shares — an estimated $189K sold.

Virtu Financial first reported a position in TNDM in Q3 2017 and held it in 8 quarters. The position peaked at $1.03M in Q4 2021. 255 funds tracked by Wall St. Rank hold TNDM as of Q3 2025.

  • Virtu Financial reported no remaining Tandem Diabetes Care position as of Q3 2025 after selling out during the quarter.
  • Virtu Financial sold 10,138 Tandem Diabetes Care shares in Q3 2025, an estimated $189K.
  • Virtu Financial first reported a position in Tandem Diabetes Care in Q3 2017 and held it in 8 quarters.
  • Virtu Financial's Tandem Diabetes Care position peaked at $1.03M in Q4 2021.
  • 255 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q3 2025.

Based on Virtu Financial's 13F filing for Q3 2025, filed 14 Nov 2025.